Curcumin activates the Wnt/β-catenin signaling pathway to alleviate hippocampal neurogenesis abnormalities caused by intermittent hypoxia: A study based on network pharmacology and experimental verification
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113299 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yao He und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China. Hauptthemen laut MEDLINE: beta Catenin, Curcumin, Hippocampus, Hypoxia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Lanzhou University First Hospital.
Abstract (Originalsprache)
The purpose of this work was to investigate how curcumin (Cur) might enhance cognitive function and to gain a better understanding of the molecular mechanisms behind Cur's impacts on neurogenesis deficits brought on by intermittent hypoxia (IH). Using network pharmacology, we explored possible targets for Cur's obstructive sleep apnea (OSA) therapy. We established an IH model using C57BL/6 mice and c17.2 cells, and we assessed the influence of Cur on treatment outcomes as well as the effect of IH on cognitive function. Hippocampal damage and neurogenesis, as well as expression of core targets, were then examined. Network pharmacology analysis revealed that Cur has the potential for multi-target, multi-pathway therapy, with CTNNB1 and MYC as core target genes. The Morris water maze test showed that Cur (100 mg/kg, intragastrically) significantly improved cognitive dysfunction induced by IH. The hematoxylin and eosin (H&E) and Nissl staining indicated that Cur could alleviate damage to the hippocampus caused by IH. Immunohistochemistry, immunofluorescence, and western blotting results showed that Cur might promote neurogenesis and upregulate the expression of β-catenin and c-myc. In vitro, Cur (0.5 μM) has a protective effect on IH-induced neural stem cells (NSCs) injury and apoptosis and can restore the Wnt/β-catenin. Cur significantly increased the neurogenesis via the Wnt/β-catenin pathway, providing the scientific groundwork for the development of new treatment strategies for neurological damage linked to OSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China.
- The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China; Department of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, China. Elect…
Förderung
- Lanzhou University First Hospital
Zitieren
APA
He, Y., Zhao, Y., Lv, R. J., Dong, N., Wang, X., Yu, Q., & Yue, H. M. (2024). Curcumin activates the Wnt/β-catenin signaling pathway to alleviate hippocampal neurogenesis abnormalities caused by intermittent hypoxia: A study based on network pharmacology and experimental verification. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113299
Vancouver
He Y, Zhao Y, Lv RJ, Dong N, Wang X, Yu Q, et al. Curcumin activates the Wnt/β-catenin signaling pathway to alleviate hippocampal neurogenesis abnormalities caused by intermittent hypoxia: A study based on network pharmacology and experimental verification. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113299
BibTeX
@article{He2024,
author = {He, Yao and Zhao, Yan and Lv, Ren-Jun and Dong, Na and Wang, Xiao and Yu, Qin and Yue, Hong-Mei},
title = {Curcumin activates the Wnt/β-catenin signaling pathway to alleviate hippocampal neurogenesis abnormalities caused by intermittent hypoxia: A study based on network pharmacology and experimental verification},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113299}
}
EUVIMED